Information  X 
Enter a valid email address

Consort Medical Plc (CSRT)

  Print      Mail a friend       Annual reports

Thursday 06 September, 2018

Consort Medical Plc

Director/PDMR Shareholding

RNS Number : 0417A
Consort Medical PLC
06 September 2018
 

Consort Medical plc

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

Consort Medical plc ("the Company") announces that the following Executive Director and Person Discharging Managerial responsibility ("PDMR")exercised an option to purchase ordinary shares under the Company's Savings Related Share Option Scheme. Following this exercise Mr. Glenn's holding has increased to 166,358 shares.

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Jonathan Glenn

 

2

 

Reason for the notification

 

a)

 

Position/status

 

 

CEO

b)

 

Initial notification /Amendment

 

 

Initial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Consort Medical plc

b)

 

LEI

 

 

2138001TBP74FD66QT38

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

Ordinary Shares of 10p each



Identification code

GB0000946276



b)

 

Nature of the transaction

 

 

Exercise of Option under the Company's Savings Related Share Option Scheme

 

 

c)

 

Price(s) and volume(s)







Price(s)

Volume(s)




£9.08

991







d)

 

Aggregated information



N/A

- Aggregated volume




- Price




e)

 

Date of the transaction

 

 

2018-09-06

f)

 

Place of the transaction

 

 

Outside a trading venue

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
DSHZQLFBVKFZBBE

a d v e r t i s e m e n t